|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:approvedBy
|
gptkb:Australia
gptkb:Canada
gptkb:European_Union
gptkb:United_Kingdom
gptkb:United_States
1986
|
|
gptkbp:ATCCode
|
N05BE01
|
|
gptkbp:brand
|
gptkb:Buspar
|
|
gptkbp:CASNumber
|
36505-84-7
|
|
gptkbp:compatibleWith
|
muscle relaxation
dependence
withdrawal symptoms
anticonvulsant effects
sedation (significant)
|
|
gptkbp:contraindication
|
concurrent use with MAO inhibitors
hypersensitivity to buspirone
|
|
gptkbp:developedBy
|
gptkb:Bristol-Myers_Squibb
|
|
gptkbp:discoveredIn
|
1970s
|
|
gptkbp:drugClass
|
gptkb:azapirone
benzodiazepine
|
|
gptkbp:eliminationHalfLife
|
2-3 hours
|
|
gptkbp:hasMolecularFormula
|
C21H31N5O2
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Buspirone
|
|
gptkbp:interactsWith
|
gptkb:beer
gptkb:milk
gptkb:rifampin
gptkb:MAO_inhibitors
gptkb:SSRIs
gptkb:ritonavir
gptkb:erythromycin
gptkb:ketoconazole
gptkb:verapamil
gptkb:linezolid
gptkb:St._John's_Wort
gptkb:nefazodone
gptkb:trazodone
cimetidine
CYP3A4 inhibitors
diltiazem
other CNS depressants
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
serotonin 5-HT1A receptor partial agonist
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:notABenzodiazepine
|
true
|
|
gptkbp:notAddictive
|
true
|
|
gptkbp:pregnancyCategory
|
B (US)
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
nausea
dizziness
headache
excitement
nervousness
lightheadedness
|
|
gptkbp:usedFor
|
gptkb:generalized_anxiety_disorder
anxiety disorders
|
|
gptkbp:bfsParent
|
gptkb:Anxiety
|
|
gptkbp:bfsLayer
|
6
|